UPDATE 3-GlaxoSmithKline lung drug fails to extend life in huge study
 

UPDATE 3-GlaxoSmithKline lung drug fails to extend life in huge study
* GSK shares down 1.5 pct; partner Theravance tumbles 15 pct (Adds further reaction, details on drug sales) http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...Ck:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...Ck:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/M-B8gq7g4PA